Abits
ABTS
SATO TECHNOLOGIES CORP
CCPUF
CATHEDRA BITCOIN INC
CBTTF
Bitdeer Technologies
BTDR
Intchains Group
ICG
US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 8.895
- +0.045+0.51%
Trading Dec 4 09:35 ET
1.27BMarket Cap-59300P/E (TTM)
8.910High8.800Low39.62KVolume8.850Open8.850Pre Close351.09KTurnover0.03%Turnover RatioLossP/E (Static)143.18MShares9.74052wk High3.28P/B1.17BFloat Cap4.71052wk Low--Dividend TTM131.70MShs Float33.972Historical High--Div YieldTTM1.24%Amplitude1.000Historical Low8.861Avg Price1Lot Size
About Aurinia Pharmaceuticals Company
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
Company Profile
SymbolAUPH
Company NameAurinia Pharmaceuticals
Listing DateFeb 25, 2000
Founded1993
CEOMr. Peter S. Greenleaf
MarketNASDAQ
Employees300
Fiscal Year Ends12-31
Address14315 – 118 Avenue,Suite 140
CityEdmonton
ProvinceAlberta
CountryCanada
Zip CodeT5L 4S6
Phone1-250-744-2487
Websitehttp://www.auriniapharma.com
Company Executives
- Name
- Position
- Salary
- Peter S. Greenleaf
- President, Chief Executive Officer and Director
- 10.57M
- Joseph M. Miller
- Chief Financial Officer and Principal Accounting Officer
- 3.98M
- Stephen P. Robertson
- Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
- 3.60M
- Matthew Donley
- Executive Vice President, Operations and Strategy
- 4.56M
- Craig A. Johnson
- Director
- --
- Kevin C. Tang
- Director
- --
- Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
- Independent Director
- 359.41K
- Dr. David R.W. Jayne, F.R.C.P.,M.D.
- Independent Director
- 249.92K
- Jill D. Leversage
- Independent Director
- 267.28K
- Jeffrey Allen Bailey
- Independent Director
- 361.51K